At Pan Cancer T, we address the major obstacles by developing next-generation TCR-T cell therapies with augmented TCR-T cells targeting novel, untapped tumor targets.

Pan Cancer T aspires to create a powerful treatment for every solid cancer patient Pan Cancer T uses its platforms to:

1. Limit toxicity attributed to recognition of identical or highly similar targets outside cancers
2. Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients
3. Technology to enhance the durability